Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating romidepsin in combination with gemcitabine in pancreatic and other advanced solid tumors has completed with results…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial comparing gemcitabine alone versus gemcitabine plus CI-994 in patients with advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Phase 2]
Clinical trial update notes that a Phase 2 study of irofulvene in stage III/IV pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the combination of RHUMAB VEGF with capecitabine-based chemoradiation for locally advanced pancreatic cancer has co…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Preop Chemoradiation Resectable Pancreas [Phase 2]
Phase 2 trial of preoperative chemoradiation for resectable pancreatic cancer completed, sponsored by M.D. Anderson Cancer Center.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Interleukin-12 in Treating Patients With Cancer in the Abdomen [Phase 1]
A Phase 1 trial evaluating interleukin-12 for abdominal cancers, including anal, colorectal, gallbladder, gastric, and pancreatic cancers, h…
-
FDA approval · 2012-07-17FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)
FDA-approved the original ANDA for fluorouracil from Eugia US LLC, granting a generic version of fluorouracil for cancer chemotherapy.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a therapy selected by molecular/metabolic profiling in patients with previously treated metastatic pancreatic cance…
-
FDA approval · 2012-07-17FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)
FDA approved the original ANDA for Fluorouracil by Eugia US LLC, enabling the marketing of a generic fluorouracil chemotherapy product.
-
CLINICAL_TRIALS research · 2012-07-16Clinical Trial Update: Isolation and Characterization of Cancer Stem Cells Using iFP Technique
A clinical trial update describing the isolation and characterization of cancer stem cells using an iFP technique in breast cancer, glioma, …
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Huachansu & Gemcitabine in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating Huachansu in combination with gemcitabine for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies [Phase 1, Phase 2]
This update reports the completion of a Phase I/II study evaluating the CEA(6D) VRP Vaccine in patients with advanced or metastatic CEA-expr…
-
CLINICAL_TRIALS research · 2012-07-09Clinical Trial Update: Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine [Phase 3]
Phase 3 trial comparing two sequencing strategies of capecitabine/erlotinib and gemcitabine for pancreatic cancer; current status/results ar…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas [Phase 3]
A Phase 3 trial evaluating fluorouracil with or without cisplatin in advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency [NA]
This clinical trial comparing Secretin-enhanced MRCP with Endoscopic Pancreatic Function Test for diagnosing pancreatic exocrine insufficien…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 trial comparing Triacetyluridine plus Fluorouracil versus Gemcitabine in unresectable locally advanced or metastatic pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms [Phase 1]
Phase 1 trial update for PF-00562271 in head and neck cancer, prostate cancer, and pancreatic cancer; the study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx [NA]
A completed Stanford-led clinical trial evaluated metabolic imaging for predicting tumor response and outcomes after pancreatic cancer treat…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating octreotide as palliation for cancer-related bowel obstruction that cannot be removed by surgery; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer [Phase 1]
This document reports an update on a Phase 1 study evaluating CP-675,206 in combination with gemcitabine in patients with previously untreat…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas [Phase 1]
Phase 1 trial of an immunostimulant antibody in combination with chemotherapy for advanced pancreatic cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction [Phase 1, Phase 2]
This multi-phase trial evaluated endoscopic placement of metal stents to treat cancer-related duodenal obstruction in patients with several …
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca [Phase 1]
A Phase I trial evaluating cetuximab (Erbitux) plus gemcitabine with radiation therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial comparing gemcitabine with vs without exatecan mesylate in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas [Phase 2]
A clinical trial update indicating completion of a Phase 2 study of the investigational drug DX-8951f in metastatic pancreatic cancer.